Skip to main content

Advertisement

Log in

Reimplantation and long-term mortality after transvenous lead extraction in a high-risk, single-center cohort

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Purpose

The use of cardiac implantable electronic devices (CIEDs) has increased significantly over the last decades. With the development of transvenous lead extraction (TLE), procedural success rates also improved; however, data regarding long-term outcomes are still limited. The aim of our study was to analyze the outcomes after TLE, including reimplantation data, all-cause and cause-specific mortality.

Methods

Data from consecutive patients undergoing TLE in our institution between 2012 and 2020 were retrospectively analyzed. Periprocedural, 30-day, long-term, and cause-specific mortalities were calculated. We examined the original and the revised CIED indications and survival rate of patients with or without reimplantation.

Results

A total of 150 patients (age 66 ± 14 years) with 308 leads (dwelling time 7.8 ± 6.3 years) underwent TLE due to pocket infection (n = 105, 70%), endocarditis (n = 35, 23%), or non-infectious indications (n = 10, 7%). All-cause mortality data were available for all patients, detailed reimplantation data in 98 cases. Procedural death rate was 2% (n = 3), 30-day mortality rate 2.6% (n = 4). During the 3.5 ± 2.4 years of follow-up, 44 patients died. Arrhythmia, as the direct cause of death, was absent. Cardiovascular cause was responsible for mortality in 25%. There was no significant survival difference between groups with or without reimplantation (p = 0.136).

Conclusions

Despite the high number of pocket and systemic infection and long dwelling times in our cohort, the short- and long-term mortality after TLE proved to be favorable. Moreover, survival without a new device was not worse compared to patients who underwent a reimplantation procedure. Our study underlines the importance of individual reassessment of the original CIED indication, to avoid unnecessary reimplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

Clinical data were retrospectively collected from consecutive patients undergoing TLE between 2012 and 2020 at the University of Szeged.

Code availability

Not applicable

References

  1. Bradshaw PJ, Stobie P, Knuiman MW, Briffa TG, Hobbs MST. Trends in the incidence and prevalence of cardiac pacemaker insertions in an ageing population. Open Hear. 2014;1.

  2. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, et al. 213 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2013;34:2281–329.

    PubMed  Google Scholar 

  3. Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the Europe. Europace. 2015;17:1601–87.

    PubMed  Google Scholar 

  4. Ponikowski P, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37:2129–2200m.

    Article  PubMed  Google Scholar 

  5. Esposito M, Kennergren C, Holmström N, Nilsson S, Eckerdal J, Thomsen P. Morphologic and immunohistochemical observations of tissues surrounding retrieved transvenous pacemaker leads. J Biomed Mater Res. 2002;63:548–58.

    Article  CAS  PubMed  Google Scholar 

  6. Perez AA, Woo FW, Tsang DC, Carrillo RG. Transvenous lead extractions: current approaches and future trends. Arrhythmia Electrophysiol Rev. 2018;7:210–7.

    Article  Google Scholar 

  7. El-Chami MF, Merchant FM. Femoral extraction of transvenous leads and leadless pacemakers—a review of the data, tools, and procedural steps. PACE - Pacing Clin Electrophysiol. 2019;42:1248–52.

    Article  PubMed  Google Scholar 

  8. Monsefi N, Waraich HS, Vamos M, Erath J, Sirat S, Moritz A, et al. Efficacy and safety of transvenous lead extraction in 108 consecutive patients: a single-centre experience. Interact Cardiovasc Thorac Surg. 2019;28:704–8.

    Article  PubMed  Google Scholar 

  9. Bongiorni MG, Kennergren C, Butter C, Deharo JC, Kutarski A, Rinaldi CA, et al. The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) registry of transvenous lead extraction outcomes. Eur Heart J. 2017;38:2995–3005.

    Article  PubMed  Google Scholar 

  10. Benak A, Kohari, M. Management of cardiac implantable electronic device infection using a complete interdisciplinary approach. 2021. https://doi.org/10.1007/s00399-020-00728-1.

  11. Al-Hijji MA, et al. Outcomes of lead extraction without subsequent device reimplantation. Europace. 2017;19:1527–34.

    PubMed  Google Scholar 

  12. Döring M, Hienzsch L, Ebert M, Lucas J, Dagres N, Kühl M, et al. Extraction of infected cardiac implantable electronic devices and the need for subsequent re-implantation. Int J Cardiol. 2020;309:84–91. https://doi.org/10.1016/j.ijcard.2019.12.044.

    Article  PubMed  Google Scholar 

  13. Gomes S, Cranney G, Bennett M, Giles R. Long-term outcomes following transvenous lead extraction. PACE - Pacing Clin Electrophysiol. 2016;39:345–51.

    Article  PubMed  Google Scholar 

  14. Merchant FM, et al. Predictors of long-term survival following transvenous extraction of defibrillator leads. PACE - Pacing Clin Electrophysiol. 2015;38:1297–303.

    Article  PubMed  Google Scholar 

  15. Diemberger I, Biffi M, Lorenzetti S, Martignani C, Raffaelli E, Ziacchi M, et al. Predictors of long-term survival free from relapses after extraction of infected CIED. Europace. 2018;20:1018–27.

    Article  PubMed  Google Scholar 

  16. Deckx S, Marynissen T, Rega F, Ector J, Nuyens D, Heidbuchel H, et al. Predictors of 30-day and 1-year mortality after transvenous lead extraction: a single-centre experience. Europace. 2014;16:1218–25.

    Article  PubMed  Google Scholar 

  17. Bongiorni MG, et al. 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: Endorsed by APHRS/HRS/LAHRS. Europace. 2018;20:1217–1217j.

    Article  PubMed  Google Scholar 

  18. Blomström-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG, et al. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), th. Europace. 2020;22:515–49.

    Article  PubMed  Google Scholar 

  19. Kusumoto FM, Schoenfeld MH, Wilkoff BL, Berul CI, Birgersdotter-Green UM, Carrillo R, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14:e503–51.

    Article  PubMed  Google Scholar 

  20. Hinkle LE, Thaler HT. Clinical classification of cardiac deaths. Circulation. 1982;65:457–64.

    Article  PubMed  Google Scholar 

  21. Milman A, et al. Predictors of short-term mortality in patients undergoing a successful uncomplicated extraction procedure. J Cardiovasc Electrophysiol. 2020;0–2. https://doi.org/10.1111/jce.14436.

  22. Maytin M, Jones SO, Epstein LM. Long-term mortality after transvenous lead extraction. Circ Arrhythm Electrophysiol. 2012;5:252–7.

    Article  CAS  PubMed  Google Scholar 

  23. Bontempi L, et al. The MB score: a new risk stratification index to predict the need for advanced tools in lead extraction procedures. EP Eur. 2020;1–9. https://doi.org/10.1093/europace/euaa027.

Download references

Acknowledgements

The valuable contribution of G.K. in the study was performed in the University of Szeged, his current affiliation is Cardiology Department, Aalborg University Hospital, Aalborg, Denmark. The technical support of Eszter Toth from Premier G. Med is also greatly appreciated.

Author information

Authors and Affiliations

Authors

Contributions

This study was designed and coordinated by A.M., G.K., A.B., L.S., and M.V. The database was designed mainly by G.K. and supplemented by M.V. Data acquisition was performed by E.J.ZS., M.M., A.V., A.B., N.S., G.K., Z.H., G.B., and M.V. Statistical analysis and interpretation of the results were carried out by E.J.ZS., M.M., A.V., A.B., L.S., and M.V. The manuscript was drafted by E.J.ZS., M.M., L.S., and M.V. and was critically revised by all the authors. E.J.ZS. and M.M. contributed equally to this work as first authors. All the authors read and confirmed the final manuscript and agreed to be accountable for all aspects of the work.

Corresponding author

Correspondence to Mate Vamos.

Ethics declarations

Ethics approval

The study was approved by the institutional review board of the University of Szeged and complies with the ethical guidelines of the Declaration of Helsinki.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Conflict of interest

M.V. reports consulting fees and/or nonfinancial support from Abott, Biotronik, Minimal Invasive Technology Ltd., and Sanofi-Aventis, outside the submitted work.

The other authors declare no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(DOCX 31 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zsigmond, EJ., Miklos, M., Vida, A. et al. Reimplantation and long-term mortality after transvenous lead extraction in a high-risk, single-center cohort. J Interv Card Electrophysiol 66, 847–855 (2023). https://doi.org/10.1007/s10840-021-00974-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-021-00974-4

Keywords

Navigation